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Research brief

FINDINGS
FROM LANDSCAPE
ANALYSIS IN KATSINA ON
PRE-ECLAMPSIA/ECLAMPSIA
Despite global efforts to reduce preventable
maternal and neonatal mortality, Nigeria’s
maternal mortality ratio is estimated at 576
deaths per 100,000 live births and neonatal
death is estimated at 37 per 1,000 live
births 1.
Maternal and newborn deaths due to pre-eclampsia and
eclampsia (PE/E) are preventable, yet in Nigeria this is the most
significant direct cause of maternal deaths.
To appreciate the enormity of this problem at country and state
levels, a landscape analysis was conducted by the Population
Council in 2015 on PE/E in seven states in Nigeria. The main
objectives of the landscape analysis were:
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•

To understand the level of programmatic and policy
support for PE/E prevention and treatment;

•

To analyze the gaps in providers’ knowledge and
competence in preventing, detecting, and managing PE/E;

•

To determine primary health care (PHC) facilities’
capacities to manage PE/E;

•

To assess community awareness, beliefs, and experiences
around PE/E;

•

To understand the volume of research on PE/E in the last
15 years; and

•

To determine priority areas for research and programmatic
interventions around PE/E.

The Ending Eclampsia project seeks to expand access
to proven, underutilized interventions and commodities
for the prevention, early detection, and treatment of preeclampsia and eclampsia and strengthen global partnerships.

PE/E IN BRIEF
• Pre-eclampsia is a condition
in pregnant women marked by an
increase in blood pressure and
protein in urine after 20 weeks
gestation.
• Providing high quality antenatal care
improves the prevention and early
detection of pre-eclampsia and can
prevent its progression to eclampsia.
• Eclampsia is a life-threatening
condition characterized by
convulsions in women with PE.
• Women in developing countries are
300 times more likely to die from
eclampsia than women in developed
countries.
• Prescribing low-dose aspirin and
calcium to at-risk women can prevent
pre-eclampsia and eclampsia.
• Pre-eclampsia and eclampsia can
be managed by administering antihypertensive drugs and magnesium
sulphate (MgSO4).
• MgSO4 is the safest and most
effective treatment for severe PE/E,
and is one of 13 UN Life-Saving
Commodities for Women and
Children.
• PE/E and other hypertensive
disorders in pregnancy increase the
risk of pre-term births, which can
lead to low birth weight, anemia, and
stunting.
• Improved prevention, increased
detection, and effective treatment
of PE/E can prevent unnecessary
maternal and newborn deaths.

The Population Council conducts research and delivers
solutions that improve lives around the world. Big
ideas supported by evidence: It’s our model for global
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FACILITY CAPACITY AND
PREPAREDNESS

TABLE 1 Signal functions for emergency obstetric
and newborn care (EmONC)

To assess institutional preparedness, researchers
visited 14 facilities in Katsina State and recorded
that four (29%) of the facilities had protocols and
guidelines available for management of pre-eclampsia
and eclampsia, six (43%) had all ANC equipment for
the detection of PE/E and six (43%) use MgSO4 for the
treatment of eclampsia.

“Yes I am aware, nationally, we
have the policy on the use of
MgSO4. Here it is cascaded down
to the state level where we have a
policy on the use of MgSO4 right
from the primary health care to
the hospital services...people have
been trained on how to use it.”
—POLICYMAKER, KATSINA
During these facility assessments, researchers
determined whether the facilities had the key ANC
equipment required to detect pre-eclampsia, manage
severe PE/E, and monitor for MgSO4 toxicity (figure 1).

PROVIDER KNOWLEDGE AND
SKILLS
Providers had good knowledge on the signs and
symptoms of E (80%) but only 40% could correctly
identify chronic hypertension in pregnancy, 46% could
correctly identified signs and symptoms of PE, and
only 13% could identify severe PE. Researchers also
assessed health care providers’ knowledge of drugs
used for preventing and managing PE/E as well as
calcium gluconate to treat MgSO4 toxicity (figure 2).

FIGURE 2 Provider knowledge of drugs for PE/E
prevention and management (n=55)

FIGURE 1 Proportion of facilities with key
equipment to detect PE and manage severe PE/E

Six (43%) of facility managers reported always using
MgSO4 to treat PE/E, four (29%) said it is sometimes
used, and four (29%) reported that it is never used.
When asked how they obtain MgSO4, 30% of managers
said they receive the drug routinely from central supply,
10% purchase it locally from the market, and 60% said
they procure it from other sources like NGOs.
Although hospitals have the capacity to provide signal
functions for emergency obstetric and neonatal care
(EmONC), Table 1 shows that PHCs have limited
capacity for conducting even basic EmONC.
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Figure 2 shows that only ten providers were aware of
the prophylactic use of drugs for women at risk of PE of
whom only two mentioned aspirin or calcium. Less than
half of all providers (49%) knew that anti-hypertensives
(aldomet or nifedipine) can be used to manage high
BP during pregnancy. The Pritchard regimen for MgSO4
administration is considered the ‘gold standard’ for
preventing and treating convulsions in severe PE/E,
but few providers (9%) could accurately describe the
appropriate doses of MgSO4 or name the antidote for
MgSO4 toxicity, calcium gluconate (13%).

QUALITY OF CARE
Quality of care was assessed through observations
of nine client-provider interactions and nine client
exit interviews with the same pregnant women.
Researchers assessed eight essential components of
quality antenatal care (ANC). Figure 3 describes the
components that clients received.

FIGURE 3 Percent of clients who received all
eight ANC components

“Within this community it is linked
to evil beliefs or attack and if she
has a rival it is linked to the rival….
Mostly it is linked to evil belief,
which is due to lack of proper
knowledge of the illness”
—RURAL WOMEN FGD

“We have no other beliefs than it
being natural…..We seek medical
help and we don’t believe in
traditional healers.“
—RURAL WOMEN FGD

In addition to the eight essential components of ANC,
questions and tests should be conducted to assess a
woman’s risk of developing PE/E, to detect PE/E, and
inform clients of the signs of impending eclampsia.
During 78% of the observed ANC consultations,
providers performed the necessary checks to detect
women at risk of developing PE. These included history
of high blood pressure (BP) and diabetes, date of last
delivery, client’s parity, age and weight, edema of
face, hands, legs, and ankles. In addition, all providers
observed in Katsina measured women’s BP and
checked urine for protein.
None of the providers, however, advised the clients
on the symptoms of impending E (severe headache,
blurred vision, and PE with generalized body swelling).

COMMUNITY KNOWLEDGE
AND PERCEPTIONS
The study also included in-depth interviews (IDIs)
and focus group discussions (FGDs) for qualitative
information from PE/E survivors, community
stakeholders, and families affected by PE/E.
Misconceptions, myths, and mistrust between
communities and health providers negatively influence
care seeking behaviors. The FGDs with men and
women reveal that people’s beliefs on pre-eclampsia
and eclampsia are divergent; some blame evil spirits,
rivals, or natural causes.

Overall, the qualitative findings show that the signs
and symptoms associated with PE/E are often
attributed to other causes and community members
often seek traditional or spiritual healing before
medical care.

SURVIVORS’ EXPERIENCES
Interviews with survivors documented their careseeking pathways, including their PE/E experience,
availability and accessibility of essential services and
commodities, and the outcomes of the pregnancy
for mother and child. Survivors’ experiences provide
insight informing strategies to work more closely with
communities and health facilities improve access to,
and use of, quality care.

“The [providers] did ask for people
with high blood pressure to come
out for measurement and I did. I
was told there was protein in my
urine [and] my blood pressure was
high. Protein was frequently seen in
my urine. To be honest, I preferred
seeing a medical Doctor on my own
without being referred so that I
could explain my condition to him.”
—PE/E SURVIVOR, KATSINA
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“I had nine pregnancies; two
miscarriages and consecutive
stillbirths before delivery. The
(ninth) was the lucky one that I
was operated upon and came out
successful. I was told when I came
for ANC that my BP was high and
I might develop convulsions or
severe high fever which might lead
(to) loss of life of both of us (mother
and baby). I attended [ANC] more
than the other pregnancies, when I
came for the 3rd visit, I was told to
stay for the operation.”
—PE/E SURVIVOR, KATSINA

DISCUSSION & CONCLUSION
This landscape analysis identified the gaps in facilities’
and providers’ capacities for preventing, detecting,
and managing PE/E; assessing community awareness,
beliefs, and experiences of PE/E; and it determined the
gaps and priority areas for research and programs to
improve access to prevention and treatment.
There are many areas of opportunity to prevent
maternal death associated with PE/E throughout
pregnancy, and different approaches to make the most
of these opportunities.
In Nigeria, all easily available anti-hypertensives for
treatment of mild to moderate hypertension (aldomet
and nifedipine) and severe hypertension (hydralazine)
are cheap and obtainable, are often available in
maternity emergency trays at most facilities and, if not,
can be purchased locally. It is imperative that future
interventions targeting providers, especially at primary
and secondary facilities, include training on antihypertensives for pregnant women.
For effective PE/E management, health facilities need
to stock the necessary drugs and ANC equipment,
and institutionalize guidelines for PE/E treatment.
Providers need to be trained and re-trained on PE
prevention—including when to administer prophylactic
drugs such as calcium supplements and aspirin—and
its early detection, and how and when to administer
anti-hypertensives and MgSO4 for early treatment of
the condition. .
4

In addition to ensuring that providers are adequately
trained to administer MgSO4 at the right time and with
the proper doses, they need to know the warning signs
for MgSO4 toxicity and its antidote, calcium gluconate.
The final, essential component to reduce mortality from
PE/E is community awareness. Community members
need to know the signs of PE/E and understand the
danger it poses for mothers and babies so they can
seek medical care promptly.
Maternal and newborn deaths due to PE/E are
preventable: by increasing community awareness of the
condition, improving antenatal care quality, and scaling
up proven best practices to prevent PE’s escalation to
severe PE/E. By detecting and managing PE, Ending
Eclampsia can improve the survival rate of women and
babies in Nigeria and other developing countries.

RECOMMENDATIONS
•

Advocacy for streamlining state procurement and
link to a national or central distribution system;

•

Connecting with United Nations Commission on
Life-Saving Commodities (UNCoLSC) for Women
and Children, especially for maternal drugs which
include MgSO4;

•

Training on quality ANC: what, why, how, when and
where;

•

Introduce task-shifting policy focusing on MNH
“policy implementation plan” to include antihypertensives and MgSO4;

•

Train PHC workers to detect and provide loading
dose of MgSO4;

•

Community awareness campaigns on the
importance of ANC and seeking care early; and

•

Engage men to encourage their support of their
wives.
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